These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26869691)

  • 41. Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes.
    de Jong E; de Jong AS; Bartels CJ; van der Rijt-van den Biggelaar C; Melchers WJ; Sturm PD
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2219-25. PubMed ID: 22327373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
    Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection.
    Stewart DB; Berg AS; Hegarty JP
    Ann Surg; 2014 Aug; 260(2):299-304. PubMed ID: 24374512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.
    Doing KM; Hintz MS; Keefe C; Horne S; LeVasseur S; Kulikowski ML
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):129-34. PubMed ID: 20117349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxin A-negative, toxin B-positive Clostridium difficile infection diagnosed by polymerase chain reaction.
    Cheng Y; Du P; Chen C; Yan S; Jia H; Wang J; Yan Q; Feng H; Lu J
    Infect Control Hosp Epidemiol; 2011 May; 32(5):520-2. PubMed ID: 21515990
    [No Abstract]   [Full Text] [Related]  

  • 46. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections.
    Hernández-Rocha C; Barra-Carrasco J; Álvarez-Lobos M; Paredes-Sabja D; Guzmán-Durán AM
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):361-5. PubMed ID: 23415540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
    Sydnor ER; Lenhart A; Trollinger B; Avdic E; Maragakis LL; Carroll KC; Cosgrove SE
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1133-6. PubMed ID: 22011545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, immunological and microbiological predictors of poor outcome in Clostridium difficile infection.
    Reigadas E; Alcalá L; Marín M; Martín A; Bouza E
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):330-334. PubMed ID: 28533000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    Russello G; Russo A; Sisto F; Scaltrito MM; Farina C
    New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
    Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
    J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.
    He T; Kaplan SE; Gomez LA; Lu X; Ramanathan LV; Kamboj M; Tang YW
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2341-2346. PubMed ID: 30242543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
    Guerrero DM; Chou C; Jury LA; Nerandzic MM; Cadnum JC; Donskey CJ
    Clin Infect Dis; 2011 Aug; 53(3):287-90. PubMed ID: 21765078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic pitfalls in Clostridium difficile infection.
    Planche T; Wilcox MH
    Infect Dis Clin North Am; 2015 Mar; 29(1):63-82. PubMed ID: 25595842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection.
    Berry N; Sewell B; Jafri S; Puli C; Vagia S; Lewis AM; Davies D; Rees E; Ch'ng CL
    J Hosp Infect; 2014 Jun; 87(2):109-14. PubMed ID: 24795170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
    Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
    J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples.
    Reigadas E; Alcalá L; Marín M; Burillo A; Muñoz P; Bouza E
    J Infect; 2015 Mar; 70(3):264-72. PubMed ID: 25452039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans.
    Reveles KR; Mortensen EM; Koeller JM; Lawson KA; Pugh MJV; Rumbellow SA; Argamany JR; Frei CR
    Pharmacotherapy; 2018 Mar; 38(3):349-356. PubMed ID: 29393522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.